| CAT No: | CL-CBCT-03 |
| CAS No: | NA |
| Mol.F: | C39H51N7O6S2 |
| Mol.Wt.: | 778 |
| Chemical Name: | Thiazol-5-ylmethyl ((2R,5R)-5-((S)-4-(N-(2-hydroxyethyl)formamido)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)butanamido)-1,6-diphenylhexan-2-yl)carbamate |
| Inventory Status: | Custom synthesis |
This impurity is related to Cobicistat Open Morpholine Impurity is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Cobicistat Open Morpholine Impurity is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:Thiazol-5-ylmethyl ((2R,5R)-5-((S)-4-(N-(2-hydroxyethyl)formamido)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)butanamido)-1,6-diphenylhexan-2-yl)carbamateCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Cobicistat Molecular Formula: C39H51N7O6S2
Molecular Weight: 778
Storage: Store in a cool, dry place.
| Product Name: | Cobicistat Open Morpholine Impurity |
| CAS No: | NA |
| Mol.F.: | C39H51N7O6S2 |
| Mol.Wt.: | 778 |
Cat. No: CL-CBCT-01
CAS No: 1004316-88-4
Mol. F: C40H53N7O5S2
Mol. Wt: 776
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-02
CAS No: 1051463-40-1
Mol. F: C40H53N7O6S2
Mol. Wt: 792
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-04
CAS No: NA
Mol. F: C40H51N7O6S2
Mol. Wt: 790
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-05
CAS No: 1051463-15-0
Mol. F: C31H41N5O4S
Mol. Wt: 579.8
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-06
CAS No: NA
Mol. F: C36H44N6O5S2
Mol. Wt: 704.9
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-07
CAS No: 1051463-24-1
Mol. F: C8H14N2OS
Mol. Wt: 186.3
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-08
CAS No: 1689522-41-5
Mol. F: C8H16N2O3
Mol. Wt: 188.2
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-09
CAS No: 1640036-98-1
Mol. F: C20H24N2O2
Mol. Wt: 324.4
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-10
CAS No: 1004316-93-1
Mol. F: C13H19N3O3S
Mol. Wt: 297.4
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-11
CAS No: NA
Mol. F: C40H53N7O5S2
Mol. Wt: 776
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-12
CAS No: 2230789-82-7
Mol. F: C40H53N7O5S2
Mol. Wt: 776
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-13
CAS No: 1051463-82-1
Mol. F: C40H53N7O5S2
Mol. Wt: 776
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-15
CAS No: NA
Mol. F: C18H22N2 : 2(HCl)
Mol. Wt: 266.4 : 2(36.5)
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-16
CAS No: 15295-77-9
Mol. F: C4H7NO2 : HBr
Mol. Wt: 101.1 : 80.9
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-17
CAS No: 1/3/2038
Mol. F: C6H14N2O
Mol. Wt: 130.2
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-18
CAS No: 2699607-48-0
Mol. F: C40H45D8N7O5S2
Mol. Wt: 784.1
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-19
CAS No: NA
Mol. F: C18H24N2 : 2(HCl)
Mol. Wt: 268.4 : 2(36.5)
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-20
CAS No: 1370406-84-0
Mol. F: C9H8N2O3S2
Mol. Wt: 256.3
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-21
CAS No: 1247119-35-2
Mol. F: C19H32N4O4S
Mol. Wt: 412.5
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-22
CAS No: 1247119-46-5
Mol. F: C12H16N4OS
Mol. Wt: 264.3
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-23
CAS No: NA
Mol. F: C28H30N4O4S2
Mol. Wt: 550.7
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-24
CAS No: NA
Mol. F: C17H28N4O4S
Mol. Wt: 384.5
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-25
CAS No: NA
Mol. F: C15H23N3O3S
Mol. Wt: 325.4
Inv. Status: Custom Synthesis
Cat. No: CL-CBCT-26
CAS No: NA
Mol. F: C32H51N7O7S2
Mol. Wt: 709.9
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: